Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label clinical trial aimed at evaluating the safety and efficacy of the combination treatment of nelmastobart with capecitabine in patients diagnosed with metastatic or recurrent colorectal cancer.